GlassScriptPhysician profile
Paul J Zbell
NPI 1124017314
$4,699.82
in general payments reported to CMS, 2019-2025
41 companies · $414 in 2025
The $414 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $966 · 2020: $708 · 2021: $1,020 · 2022: $413 · 2023: $447 · 2024: $731 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576 · Entertainment: $15.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.41 |
| Entertainment | $15.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $508.38 | 2019-2022 | |
| Astellas Pharma US INC | $494.35 | 2019-2024 | Myrbetriq |
| Myriad Genetic Laboratories, INC. | $379.18 | 2020-2025 | Prolaris |
| Medtronic USA, INC. | $347.05 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $318.57 | 2019-2024 | Xiaflex |
| Allergan, INC. | $282.86 | 2019-2022 | |
| Antares Pharma, INC. | $223.63 | 2019-2025 | Xyosted |
| Boston Scientific Corporation | $197.15 | 2019-2024 | Lithovue, Solyx Sis System, Lumenis Pulse 120h |
| Medtronic, INC. | $175.87 | 2021-2024 | Interstim |
| Procept Biorobotics Corporation | $171.14 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Pfizer INC. | $158.95 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $126.29 | 2024-2025 | Gemtesa |
| Teleflex LLC | $115.93 | 2025 | Barrigel |
| Olympus America INC. | $114.80 | 2019-2025 | Itind System, Olympus |
| Axonics, INC. | $105.78 | 2022-2024 | Axonics |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $94.61 | 2021 | |
| Urovant Sciences INC | $83.39 | 2021-2022 | |
| 180 Medical, INC. | $83.21 | 2021 | |
| Abbvie INC. | $64.64 | 2023-2025 | Botox, Dalvance |
| Zyla Life Sciences, INC. | $59.98 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $55.46 | 2019-2020 | |
| Edap Technomed INC | $51.18 | 2024-2025 | |
| Endo USA, INC. | $45.81 | 2024 | Xiaflex |
| Rochester Medical Corporation | $42.93 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $37.24 | 2024-2025 | Adstiladrin |
| Kerecis Limited | $37.16 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Janssen Biotech, INC. | $36.07 | 2019 | |
| Dendreon Pharmaceuticals LLC | $34.26 | 2019 | |
| Angiodynamics, INC. | $30.88 | 2022-2024 | Nanoknife |
| Tolmar, INC. | $26.13 | 2023 | |
| Innovation Technologies INC | $25.00 | 2024 | Irrisept |
| Blue Earth Diagnostics | $24.55 | 2019 | |
| Travere Therapeutics, INC. | $20.77 | 2019-2022 | |
| Photocure INC | $18.73 | 2021 | |
| Accord Healthcare, INC. | $17.96 | 2024 | |
| Ethicon US, LLC | $16.71 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.73 | 2019 | |
| Calyxo, INC. | $15.46 | 2024 | Cvac Aspiration System |
| Profound Medical Corp. | $14.41 | 2022 | |
| Urogen Pharma, INC. | $14.38 | 2022 | |
| Progenics Pharmaceuticals, INC. | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Zbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.